Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged >50 years.
about
HIV and Menopause: A Systematic Review of the Effects of HIV Infection on Age at Menopause and the Effects of Menopause on Response to Antiretroviral TherapyHIV Infection in the Elderly: Arising ChallengesA missing piece in the puzzle: HIV in mature adults in sub-Saharan AfricaPrevalence and risk factors of poor immune recovery among adult HIV patients attending care and treatment centre in northwestern Tanzania following the use of highly active antiretroviral therapy: a retrospective study.Characteristics and outcomes of older HIV-infected patients receiving antiretroviral therapy in Malawi: A retrospective observation cohort study.Virologic and immunologic response to HAART, by age and regimen classMortality and immunological recovery among older adults on antiretroviral therapy at a large urban HIV clinic in Kampala, Uganda.CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?HIV infection in the elderlyLong-term CD4+ cell count in response to combination antiretroviral therapy.Age, sex, and nutritional status modify the CD4+ T-cell recovery rate in HIV-tuberculosis co-infected patients on combination antiretroviral therapyDefinition of advanced age in HIV infection: looking for an age cut-off.Immunological and Clinical Responses following the Use of Antiretroviral Therapy among Elderly HIV-Infected Individuals Attending Care and Treatment Clinic in Northwestern Tanzania: A Retrospective Cohort StudyImpact of age on markers of HIV-1 diseaseEffect of age and HAART regimen on clinical response in an urban cohort of HIV-infected individuals.Pharmacologic consideration for the use of antiretroviral agents in the elderly.Epidemiology of HIV and response to antiretroviral therapy in the middle aged and elderly.Aging, antiretrovirals, and adherence: a meta analysis of adherence among older HIV-infected individuals.Antiretroviral Treatment Efficacy and Safety in Older HIV-Infected Adults.Impact of Age-related Comorbidities on Five-year Overall Mortality among Elderly HIV-Infected Patients in the Late HAART Era--Role of Chronic Renal Disease.Increased costs of HIV care associated with aging in an HIV-infected population.Safety, efficacy, and persistence of emtricitabine/tenofovir versus other nucleoside analogues in naive subjects aged 50 years or older in Spain: the TRIP study.
P2860
Q26852180-01CFF7F9-3229-489F-BCF0-68B459B982C5Q28076000-FA6AAEDD-8897-42EF-9B6F-EE5216F64B4EQ33353214-CE2EAFB6-EA75-49F9-AF71-4271966139BCQ33781469-16A0BD06-2FE8-4AB9-AFD6-B1DBF91C439AQ33883748-41B61E1E-7C57-4EAC-9AAD-E99C42099C7CQ34137148-45A28819-AD0C-4C70-A4FA-0FA444323A2AQ34443404-24862BE1-5BF3-45D9-BEF6-C337DF5945FDQ34499000-A03D24EB-2008-4C18-8DB3-02B10F649B98Q35086332-4BF28D70-B45C-41D2-858C-B9855A4A66A3Q35138526-97561D4B-852B-43A2-B746-5A1C10A3D7C9Q35836400-CE665440-6E39-4FEC-9724-5FF90BA9BA57Q36177972-F02FAB10-9B9A-43CA-B91F-FB0BC2BAC13DQ36693723-5CB74A4E-FB40-4348-8606-DE7C0A5E5827Q36763762-287E8A34-3723-4893-946E-32869D352DD6Q37003774-5FB64923-E9BF-4E6F-88B6-6820C2A75092Q37277510-6D1C03FC-A034-4A16-904C-0769598AC597Q37419826-744F85D3-C87F-4D26-BE18-5BC046D3C11BQ38130178-5A06C74B-7B37-4169-A988-FE44A3999E47Q38673884-56C4B8D5-801E-4666-B1CA-D547B72C4093Q40747316-496E6D86-F1BC-405F-B5EB-FF38D417A126Q42202635-805B5306-5194-4AFF-86BF-DE957C2F7F7CQ42243459-DB738B4C-BF39-46E2-A62C-E069ECB95918
P2860
Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged >50 years.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Immunologic and clinical respo ...... HIV infection aged >50 years.
@en
type
label
Immunologic and clinical respo ...... HIV infection aged >50 years.
@en
prefLabel
Immunologic and clinical respo ...... HIV infection aged >50 years.
@en
P2093
P356
P1476
Immunologic and clinical respo ...... h HIV infection aged >50 years
@en
P2093
Bruno Marchou
Lise Cuzin
Patrice Massip
Stéphane Gerard
P304
P356
10.1086/520652
P407
P50
P577
2007-07-19T00:00:00Z